The cytotoxicity of Cisplatin (CDDP) is traditionally believed to be cell cycle independent. This general belief is not in agreement with CDDP-induced apoptosis. Therefore, cell cycle dependency of cisplatin was investigated using human ovarian carcinoma OV 2008 cell line synchronized at the different phases of the cell cycle (i.e. subpopulations). Clonogenic assay, flow cytometry, fluorescence microscopy, electron microscopy (EM), atomic absorption spectroscopy (AA), and various biochemical techniques were used in this project. OV 2008 cell subpopulations at the different phases of G1, G1/S, S and G2/M were exposed to 1 m g/ml of CDDP for one hour (n = 3). CDDP resulted in 66 +/- 6(SE)%, 50 +/- 6%, 42 +/- 5%, and 41 +/- 5% su...
Objective: Ovarian cancer (OvCa) cells that are highly aggressive or possess cancer-stem-like proper...
Testicular germ cell tumours are amongst the most chemosensitive neoplasms both in vivo and in vitro...
Background: Regulators of cell cycle phase transitions could be important targets for cancer treatme...
Cis-Diamminedichloroplatinum(II) (CDDP) is used in the treatment of various cancers, with or without...
Cis-diamminedichloroplatinum (II) cisplatin (CDDP) is an organometallic compound frequently used in...
The aim of our study was to determine the effect of selected cytostatics on a human ovarian cancer c...
Studies were undertaken to investigate acquired resistance to cisplatin in human ovarian cancer cell...
<p><b>A.</b> Dose-dependent effects of cisplatin in ovarian cell lines. Cells were exposed to cispla...
Cisplatin (CDDP) resistance mechanisms were studied in a model of three germ cell tumour and three c...
BACKGROUND: Time-dependence of cisplatin (CDDP) and oxaliplatin (L-OHP) cytotoxic effects in A431 a...
We investigated cisplatin-induced apoptosis and the effects on cell cycle-related proteins and cell ...
Includes bibliographical references (pages [201]-214).Cisplatin (c/s-diamminedichloroplatinum (II)) ...
In an attempt to examine the cellular changes associated with cisplatin resistance, we selected a ci...
<p>A2780/C30 cells (representative of the two OC cell lines) were treated (A) with cisplatin (0–100μ...
AIM: To investigate mechanisms by which doxorubicin (DOX) and cisplatin (CIS) cause human ovarian st...
Objective: Ovarian cancer (OvCa) cells that are highly aggressive or possess cancer-stem-like proper...
Testicular germ cell tumours are amongst the most chemosensitive neoplasms both in vivo and in vitro...
Background: Regulators of cell cycle phase transitions could be important targets for cancer treatme...
Cis-Diamminedichloroplatinum(II) (CDDP) is used in the treatment of various cancers, with or without...
Cis-diamminedichloroplatinum (II) cisplatin (CDDP) is an organometallic compound frequently used in...
The aim of our study was to determine the effect of selected cytostatics on a human ovarian cancer c...
Studies were undertaken to investigate acquired resistance to cisplatin in human ovarian cancer cell...
<p><b>A.</b> Dose-dependent effects of cisplatin in ovarian cell lines. Cells were exposed to cispla...
Cisplatin (CDDP) resistance mechanisms were studied in a model of three germ cell tumour and three c...
BACKGROUND: Time-dependence of cisplatin (CDDP) and oxaliplatin (L-OHP) cytotoxic effects in A431 a...
We investigated cisplatin-induced apoptosis and the effects on cell cycle-related proteins and cell ...
Includes bibliographical references (pages [201]-214).Cisplatin (c/s-diamminedichloroplatinum (II)) ...
In an attempt to examine the cellular changes associated with cisplatin resistance, we selected a ci...
<p>A2780/C30 cells (representative of the two OC cell lines) were treated (A) with cisplatin (0–100μ...
AIM: To investigate mechanisms by which doxorubicin (DOX) and cisplatin (CIS) cause human ovarian st...
Objective: Ovarian cancer (OvCa) cells that are highly aggressive or possess cancer-stem-like proper...
Testicular germ cell tumours are amongst the most chemosensitive neoplasms both in vivo and in vitro...
Background: Regulators of cell cycle phase transitions could be important targets for cancer treatme...